Alteration of Colonic Mucosal Permeability during Antibiotic-Induced Dysbiosis

Int J Mol Sci. 2020 Aug 25;21(17):6108. doi: 10.3390/ijms21176108.

Abstract

Although dysbiosis is likely to disturb the mucosal barrier system, the mechanism involved has remained unclear. Here, we investigated alterations of colonic mucosal permeability and tight junction (TJ) molecules in mice with antibiotic-induced dysbiosis. Mice were orally administered vancomycin or polymyxin B for 7 days, and then fecal samples were subjected to microbial 16S rRNA analysis. The colonic mucosal permeability was evaluated by chamber assay. The colonic expression of TJ molecules and cytokines was examined by real-time RT-PCR, Western blotting, and immunohistochemistry. Caco2 cells were stimulated with cytokines and their transepithelial electric resistance (TEER) was measured. Vancomycin-treated mice showed significantly lower gut microbiota diversity than controls, and the same tendency was evident in polymyxin B-treated mice. The colonic mucosal permeability was significantly elevated in both vancomycin- and polymyxin B-treated mice. The expression of claudin 4 in the colonic mucosa was decreased in both vancomycin- and polymyxin B-treated mice. Colonic expression of TNF-α and/or IFN-γ was significantly increased in mice that had been administered antibiotics. TNF-α and IFN-γ stimulation dose-dependently decreased TEER in Caco2 cells. Antibiotic-induced dysbiosis is correlated with the enhancement in colonic tissue permeability, accompanied by a reduction in claudin 4 expression and enhancement in TNF-α and/or IFN-γ expression in mice.

Keywords: antibiotic; claudin; colorectal; cytokine; dysbiosis; gut microbiome; permeability; polymyxin B; tight junction; vancomycin.

MeSH terms

  • Administration, Oral
  • Animals
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / adverse effects*
  • Bacteria / classification*
  • Bacteria / genetics
  • Bacteria / isolation & purification
  • Cytokines / genetics
  • Cytokines / metabolism
  • Disease Models, Animal
  • Dysbiosis / chemically induced
  • Dysbiosis / genetics
  • Dysbiosis / metabolism*
  • Feces / microbiology
  • Humans
  • Intestinal Mucosa / drug effects
  • Intestinal Mucosa / metabolism*
  • Mice
  • Permeability / drug effects
  • Phylogeny
  • Polymyxin B / administration & dosage
  • Polymyxin B / adverse effects
  • RNA, Ribosomal, 16S / genetics
  • Sequence Analysis, RNA
  • Tight Junction Proteins / genetics
  • Tight Junction Proteins / metabolism*
  • Vancomycin / administration & dosage
  • Vancomycin / adverse effects

Substances

  • Anti-Bacterial Agents
  • Cytokines
  • RNA, Ribosomal, 16S
  • Tight Junction Proteins
  • Vancomycin
  • Polymyxin B